Article Sidebar

Submitted
10 February 2024
Accepted
1 April 2024
Published
10 March 2024
Download
PDF
Statistic
Read Counter : 96 Download : 58

Main Article Content

Abstract

Highlights:
1. An examination of IL-4 and IL-5 expressions in nodular prurigo and pruritic papular eruption is crucial for enhancing the effectiveness of biological agent therapy, specifically for HIV/AIDS patients.
2. The findings offer evidence suggesting the possibility of IL-4 as a treatment target for individuals diagnosed with nodular prurigo, as well as IL-4 and IL-5 for those diagnosed with pruritic papular eruption.



Abstract
Pruritic papular eruption is a dermatosis characterized by pruritic symptoms in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). Similarly, nodular prurigo is an itchy dermatosis with lesions and histopathological features that resemble those of pruritic papular eruption. Both conditions share a common etiopathogenesis, which involves the cytokines produced by T helper 2 (Th2) cells. Nodular prurigo and pruritic papular eruption are chronic and frequently recalcitrant, thus posing challenges in treatment. The use of biological agents represents a treatment development for chronic and recalcitrant dermatoses. This study aimed to determine the difference in the mean percentage of interleukin-4 (IL-4) and interleukin-5 (IL-5) expressions between nodular prurigo and pruritic papular eruption lesions, which may establish a basis for further biological agent therapy. A cross-sectional study was conducted using paraffin block preparations of the skin lesions of patients diagnosed with nodular prurigo (n=16) and pruritic papular eruption (n=16). Each paraffin block preparation involved immunohistochemical staining using IL-4 and IL-5 monoclonal antibodies. The expressions of IL-4 and IL-5 were assessed through ImageJ for Windows, version 1.53 (National Institutes of Health and the Laboratory for Optical and Computational Instrumentation, University of Wisconsin, USA) by pathologists. The data were analyzed using an unpaired t-test with a significance level of p<0.05. The analytical results indicated that data on the average age of the two groups, disease duration, and storage sample duration followed a normal distribution (p>0.05). The mean percentage of IL-4 expression was significantly different between the nodular prurigo and pruritic papular eruption groups (p=0.000). However, the mean percentage of IL-5 expression was not significantly different between the two groups (p=0.060). In conclusion, the expression of IL-4 was higher in the nodular prurigo group in comparison to the pruritic papular eruption group. Nonetheless, the expression of IL-5 was comparably high in both the nodular prurigo and pruritic papular eruption groups.

Keywords

Human immunodeficiency virus (HIV) interleukin-4 interleukin-5 immunohistochemistry

Article Details

License

Copyright (c) 2024 Folia Medica Indonesiana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Ayu Wikan Sayekti, Ann Kautsaria Putri, Dwi Retno Adi Winarni, & Satiti Retno Pudjiati. (2024). Expressions of Interleukin-4 and Interleukin-5 in Nodular Prurigo and Pruritic Papular Lesions. Folia Medica Indonesiana, 60(1), 47–53. https://doi.org/10.20473/fmi.v60i1.55017
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Agrawal D, Sardana K, Mathachan SR, et al (2022). A prospective study examining the expression of STAT 1, 3, 6 in prurigo nodularis lesions with its immunopathogenic and therapeutic implications. Journal of Cosmetic Dermatology 21, 4009–4015. doi: 10.1111/jocd.14709.
  2. Amsen D, Visser KE, Town T (2009). Approaches to determine expression of inflammatory cytokines. 107–42. Available at: http://link.spring er.com/10.1007/978-1-59745-447-6_5.
  3. Chimbetete T, Buck C, Choshi P, et al (2023). HIV-associated immune dysregulation in the skin: A crucible for exaggerated inflammation and hypersensitivity. Journal of Investigative Dermatology 143, 362–373. doi: 10.1016/j.jid.202 2.07.035.
  4. Chua SL, Amerson EH, Leslie KS, et al (2014). Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era. British Journal of Dermatology 170, 832–839. doi: 10.1111/bjd. 12721.
  5. Ekpe O (2019). Pruritic papular eruption of HIV: a review article. Our Dermatology Online 10, 191–196. doi: 10.7241/ourd.20192.22.
  6. Garg T, Sanke S (2017). Inflammatory dermatoses in human immunodeficiency virus. Indian Journal of Sexually Transmitted Diseases and AIDS 38, 113. doi: 10.4103/ijstd.IJSTD_22_17.
  7. Grillo F, Bruzzone M, Pigozzi S, et al (2017). Immunohistochemistry on old archival paraffin blocks: is there an expiry date?. Journal of Clinical Pathology 70, 988–993. doi: 10.1136/jclinpath-2017-204387.
  8. Grillo F, Pigozzi S, Ceriolo P, et al (2015). Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections. Histochemistry and Cell Biology 144, 93–99. doi: 10.1007/s00418-015-1316-4.
  9. Heeb LEM, Egholm C, Boyman O (2020). Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils. Genes & Immunity 21, 143–149. doi: 10.1038/s41435-020-0095-7.
  10. IBM Corp (2017). IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp. Available at: https://www.ibm.com/id-id/products /spss-statistics.
  11. Jung JH, Kang IG, Kim DY, et al (2013). The effect of Korean red ginseng on allergic inflammation in a murine model of allergic rhinitis. Journal of Ginseng Research 37, 167–175. doi: 10.5142/jgr.2013.37.167.
  12. Kaminuma O, Nishimura T, Kitamura N, et al. (2018). T-helper type 2 cells direct antigen-induced eosinophilic skin inflammation in mice. Allergy, Asthma & Immunology Research 10, 77. doi: 10.4168/aair.2018.10.1.77.
  13. Keustermans GCE, Hoeks SBE, Meerding JM, et al (2013). Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples. Methods 61, 10–17. doi: 10.1016/j.yme th.2013.04.005.
  14. Kim HY (2019). Statistical notes for clinical researchers: the independent samples t -test. Restorative Dentistry & Endodontics. doi: 10.5395/rde.2019.44.e26.
  15. Maity B, Sheff D, Fisher RA (2013). Immunostaining. 81–105. Available at: https://linkinghub.elsevier.com/retrieve/pii/B9780124072398000057.
  16. Mohammed S, Vellaisamy S, Gopalan K, et al (2019). Prevalence of pruritic papular eruption among HIV patients: A cross-sectional study. Indian Journal of Sexually Transmitted Diseases and AIDS 40, 146. doi: 10.4103/ijstd.IJSTD_ 69_18.
  17. Ness RB (2004). Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. American Journal of Epidemiology 160, 1033–1038. doi: 10.1093/aje/kwh325.
  18. Shao Y, Wang D, Zhu Y, et al (2023). Molecular mechanisms of pruritus in prurigo nodularis. Frontiers in Immunology. doi: 10.3389/fimmu. 2023.1301817.
  19. Statistics Indonesia (2020). Elderly population statistics 2020. Statistics Indonesia, Jakarta. Available at: https://www.bps.go.id/id/publica tion/2020/12/21/0fc023221965624a644c1111/statistik-penduduk-lanjut-usia-2020.html.
  20. Vijayan KKV, Karthigeyan KP, Tripathi SP, et al (2017). Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections. Frontiers in Immunology. doi: 10.3389/fimmu.2017.00580.
  21. Wang Y, Dong C, Han Y, et al (2022). Immunosenescence, aging and successful aging. Frontiers in Immunology. doi: 10.3389/fimmu.20 22.942796.
  22. Williams KA, Huang AH, Belzberg M, et al (2020). Prurigo nodularis. Journal of the American Academy of Dermatology 83, 1567–1575. doi: 10.1016/j.jaad.2020.04.182.
  23. Wong LS, Yen YT (2022). Chronic nodular prurigo: An update on the pathogenesis and treatment. International Journal of Molecular Sciences 23, 12390. doi: 10.3390/ijms232012390.
  24. Wu AY, Sur S, Grant JA, et al (2019). Interleukin-4/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthma. Current Opinion in Allergy & Clinical Immunology 19, 30–37. doi: 10.1097/ACI.0000000000000490.
  25. Yao S, Hong C-C, Ruiz-Narváez EA, et al (2018). Genetic ancestry and population differences in levels of inflammatory cytokines in women: Role for evolutionary selection and environmental factors ed. Reiner AP. PLOS Genetics 14, e1007368. doi: 10.1371/journal.pgen.1007368.
  26. Zeidler C, Pereira M, Ständer S (2019). The neuromodulatory effect of antipruritic treatment of chronic prurigo. Dermatology and Therapy 9, 613–622. doi: 10.1007/s13555-019-00321-6.